kabutan

KOBAYASHI PHARMA, Ordinary Profit Forecast for Last Fiscal Year Revised Upward by 10%

Tue Feb 3, 2026 3:30 pm JST Revision

4967 KOBAYASHI PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Guidance Update Report

KOBAYASHI PHARMACEUTICAL CO.,LTD. <4967> [TSE Prime] announced a performance revision after the market closed on February 3rd (15:30). The consolidated ordinary profit forecast for the fiscal year ending December 2025 has been revised upward 10.5%, from the previous forecast of 15.3 billion yen to 16.9 billion yen (compared to 26.8 billion yen in the previous period), and the declining rate is expected to decrease from 43.0% to 37.1%. However, the full-year forecast for consolidated net income has decreased 65.7%, from the previous forecast of 10.5 billion yen to 3.60 billion yen (compared to 10.0 billion yen in the previous period). This changes the outlook from an anticipated profit increase to a projection of a 64.2% decrease in profit.

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the July to December period (second half) consolidated ordinary profit has been revised upward 19.9%, from the previous forecast of 8.05 billion yen to 9.65 billion yen (compared to 16.4 billion yen in the same period of the previous year), and the declining rate is expected to decrease from 51.0% to 41.2%.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2025 Prev 101,982 7,352 8,055 7,333 98.7 60 Aug 5, 2025 J-GAAP
Jul - Dec, 2025 New 96,682 8,252 9,655 433 5.8 60 Feb 3, 2026 J-GAAP
Revision Rate -5.2% +12.2% +19.9% -94.1% -94.1%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Prev 171,000 14,000 15,300 10,500 141.3 104 Feb 10, 2025 J-GAAP
Dec, 2025 New 165,700 14,900 16,900 3,600 48.4 104 Feb 3, 2026 J-GAAP
Revision Rate -3.1% +6.4% +10.5% -65.7% -65.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 92,464 15,389 16,427 8,631 116.1 59 Feb 10, 2025 J-GAAP
Jul - Dec, 2025 Guidance 96,682 8,252 9,655 433 5.8 60 Feb 3, 2026 J-GAAP
YoY +4.6% -46.4% -41.2% -95.0% -95.0%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 173,455 25,780 27,330 20,338 268.2 101 Feb 9, 2024 J-GAAP
Dec, 2024 165,600 24,860 26,861 10,067 135.4 102 Feb 10, 2025 J-GAAP
Dec, 2025 Guidance 165,700 14,900 16,900 3,600 48.4 104 Feb 3, 2026 J-GAAP
YoY +0.1% -40.1% -37.1% -64.2% -64.2%

Related Articles